Literature DB >> 29567772

Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2.

Constance Baer1, Verena Muehlbacher2, Wolfgang Kern2, Claudia Haferlach2, Torsten Haferlach2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29567772      PMCID： PMC6068021          DOI： 10.3324/haematol.2017.187302

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Acute Myeloid Leukemia.

Authors:  Hartmut Döhner; Daniel J Weisdorf; Clara D Bloomfield
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

2.  Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.

Authors:  Animesh Pardanani; Terra Lasho; Daniela Barraco; Mrinal Patnaik; Yoseph Elala; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2016-01-11       Impact factor: 10.047

3.  Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.

Authors:  Manja Meggendorfer; Torsten Haferlach; Tamara Alpermann; Sabine Jeromin; Claudia Haferlach; Wolfgang Kern; Susanne Schnittger
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

4.  Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing.

Authors:  Anna Stengel; Niroshan Nadarajah; Torsten Haferlach; Frank Dicker; Wolfgang Kern; Manja Meggendorfer; Claudia Haferlach
Journal:  Leukemia       Date:  2018-02-26       Impact factor: 11.528

5.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 6.  Myeloid neoplasms with eosinophilia.

Authors:  Andreas Reiter; Jason Gotlib
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

8.  Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.

Authors:  Verena Patterer; Susanne Schnittger; Wolfgang Kern; Torsten Haferlach; Claudia Haferlach
Journal:  Ann Hematol       Date:  2013-02-12       Impact factor: 3.673

9.  Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

Authors:  Jane F Apperley; Martine Gardembas; Junia V Melo; Robin Russell-Jones; Barbara J Bain; E Joanna Baxter; Andrew Chase; Judith M Chessells; Marie Colombat; Claire E Dearden; Sasa Dimitrijevic; François-X Mahon; David Marin; Zariana Nikolova; Eduardo Olavarria; Sandra Silberman; Beate Schultheis; Nicholas C P Cross; John M Goldman
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.

Authors:  Arjan Buijs; Merel van Wijnen; Dorine van den Blink; Mariëlle van Gijn; Saskia K Klein
Journal:  Cancer Genet       Date:  2013-04
View more
  11 in total

1.  FGFR1 Rearrangement Guides Diagnosis and Treatment of a Trilineage B, T, and Myeloid Mixed Phenotype Acute Leukemia.

Authors:  Ying Liu; Xiaoli Mi; Ramya Gadde; Qi Gao; Wenbin Xiao; Yanming Zhang; Rayma Benayed; Maria Arcila; Ahmet Dogan; Mark B Geyer; Mikhail Roshal
Journal:  JCO Precis Oncol       Date:  2020-08-25

Review 2.  Updates on eosinophilic disorders.

Authors:  Alexandar Tzankov; Kaaren K Reichard; Robert P Hasserjian; Daniel A Arber; Attilio Orazi; Sa A Wang
Journal:  Virchows Arch       Date:  2022-09-07       Impact factor: 4.535

3.  What went wrong with variant effect predictor performance for the PCM1 challenge.

Authors:  Maximilian Miller; Yanran Wang; Yana Bromberg
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.700

4.  Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT.

Authors:  Juan-Carlos Hernández-Boluda; Arturo Pereira; Nienke Zinger; Luuk Gras; Rodrigo Martino; Emmanouil Nikolousis; Jürgen Finke; Anabelle Chinea; Alessandro Rambaldi; Marie Robin; Riccardo Saccardi; Annalisa Natale; John A Snowden; Panagiotis Tsirigotis; Carlos Vallejo; Gerald Wulf; Blanca Xicoy; Domenico Russo; Johan Maertens; Etienne Daguindau; Stig Lenhoff; Patrick Hayden; Tomasz Czerw; Donal P McLornan; Ibrahim Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2022-01-23       Impact factor: 5.174

5.  Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention.

Authors:  Gloria Pelizzo; Luigi Chiricosta; Emanuela Mazzon; Gian Vincenzo Zuccotti; Maria Antonietta Avanzini; Stefania Croce; Mario Lima; Placido Bramanti; Valeria Calcaterra
Journal:  Pediatr Rep       Date:  2021-01-05

6.  Myeloid neoplasm with eosinophilia and rearrangement of platelet-derived growth factor receptor beta gene in children: Two case reports.

Authors:  Shi-Chong Wang; Wen-Yu Yang
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

7.  Myeloid tumors accompanying systemic mastocytosis, basophilia, and abnormal platelet-derived growth factor receptor β: A case report.

Authors:  Yanfen Li; Yu Jing; Hua Wan; Daihong Liu
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

8.  Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.

Authors:  Danika Di Giacomo; Martina Quintini; Valentina Pierini; Fabrizia Pellanera; Roberta La Starza; Paolo Gorello; Caterina Matteucci; Barbara Crescenzi; Paolo Fabio Fiumara; Marinella Veltroni; Erika Borlenghi; Francesco Albano; Fabio Forghieri; Monica Maccaferri; Francesca Bettelli; Mario Luppi; Antonio Cuneo; Giuseppe Rossi; Cristina Mecucci
Journal:  Ann Hematol       Date:  2021-12-02       Impact factor: 3.673

Review 9.  Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.

Authors:  Elvin D de Araujo; Anna Orlova; Heidi A Neubauer; Dávid Bajusz; Hyuk-Soo Seo; Sirano Dhe-Paganon; György M Keserű; Richard Moriggl; Patrick T Gunning
Journal:  Cancers (Basel)       Date:  2019-11-08       Impact factor: 6.639

Review 10.  The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.

Authors:  Asumi Yokota; Li Huo; Fengli Lan; Jianqiang Wu; Gang Huang
Journal:  Mol Cells       Date:  2020-02-29       Impact factor: 5.034
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.